AUSTRALIA Trends and Developments Contributed by: Suzy Madar, Matthew Swinn, Kate Hay and Scott Bouvier, Mallesons
Population Health: Prevention, Aging and System Sustainability Population health considerations sit at the centre of Australia’s life sciences outlook for 2026. Demograph- ic change – particularly Australia’s aging population – is the single largest driver of healthcare demand and expenditure. Australians aged 65 and over now represent a growing segment of the population and account for a disproportionate share of healthcare utilisation and spending. Products and services are increasingly used over longer horizons, often in homes and community settings, by patients with multiple comorbidities. This raises important considerations for evidence, usability, labelling, risk communication, and monitoring of adverse outcomes, particularly as products move from specialist and acute settings into primary care, aged care and the home, where assumptions about supervision, training and escala- tion no longer hold. This demographic pressure is accelerating a sector- wide shift towards prevention, early intervention and integrated care. As chronic disease management, allied health services and mental health care expand rapidly under policy initiatives and changing consumer expectations, new tools are emerging to support this shift. Digital mental health platforms and remote monitoring technologies raise questions about safety thresholds, evidence standards and workforce scope of practice, particularly when services are delivered to vulnerable cohorts outside traditional clinical settings. Mental health has become a particular focus, as height- ened awareness of its social and economic impacts, together with advances in treatment and digital sup- port tools, drives demand for new service models. At the same time, allied health services are capturing a growing share of healthcare revenue, reflecting broad- er recognition that prevention and early intervention are critical to system sustainability. These system-level pressures are particularly acute for First Nations communities, where improved outcomes depend on more than access alone. Programmes must embed data sovereignty, culturally safe con- sent, and community governance into design, evalu- ation and operational systems, with implications for
reputational risk where expectations around access, price and outcomes are not met. High-cost advanced therapies and personalised medicine further challenge conventional funding frameworks. In response, there is increasing interest in outcomes-based reimbursement, staged payment arrangements and risk-sharing models tied to real- world performance. While these approaches offer potential sustainability benefits, they raise novel legal and operational issues, including: • data collection and verification obligations; • performance metrics; • audit rights; • dispute resolution mechanisms; and • long-term enforcement risk, particularly where benefits and safety signals emerge over extended time periods. Patient and consumer attitudes are also shifting. Patients are increasingly accustomed to digital inter- faces, rapid access and transparency around price and performance, and are more willing to compare providers, platforms and treatment options across traditional healthcare and consumer services. This has heightened sensitivity to claims, representations and user experience, particularly where digital health tools, wellness products or hybrid care models are marketed directly to consumers. For providers and platforms, this shift amplifies the importance of clear disclosures, substantiated claims and effective com- plaints-handling frameworks, as consumer expecta- tions increasingly shape both regulatory scrutiny and litigation risk. The private sector is playing a more active role in shaping access pathways. Insurers, employers and technology platforms are increasingly involved in care co-ordination, preventative care and digital health delivery, often operating alongside or in place of tradi- tional providers. This blurring of boundaries between healthcare and consumer services has implications for competition law, consumer protection and regulatory oversight, particularly as vertically integrated models emerge.
28 CHAMBERS.COM
Powered by FlippingBook